Reston Ebola: NOVA’s Namesake Emerging Infectious Disease

By Chris Healey

Almost 25 years before the 2014 Ebola epidemic began spreading through West Africa – and the resulting treatment of two American Ebola patients on U.S. soil – public health officials responded to an Ebola outbreak inside the U.S.

Reston Ebola is the name given to an Ebola species discovered among macaque monkeys in a pharmaceutical research company’s primate quarantine unit in Reston, VA.

In 1989, a veterinarian at Hazelton Research Products, a pharmaceutical research company, contacted the United States Army Institute of Infectious Diseases at Fort Detrick, MD, concerning an unusually high mortality rate among macaques in a shipment from the Philippines. The veterinarian wanted USAMRIID to confirm suspected simian hemorrhagic fever, a viral illness lethal to primates but innocuous to humans. Tests on macaque carcasses unexpectedly showed signs of a deadly filovirus infection – Ebola hemorrhagic fever virus.

Initially, Ebola species Zaire – with mortality rates as high as 90%, and the cause of the 2014 African Ebola epidemic – was implicated as the agent at work. Faced with an unprecedented public health threat, state and federal health agencies converged on the primate quarantine facility in Reston. The Centers for Disease Control and Prevention monitored quarantine facility employees for Ebola symptoms. USAMRIID euthanized primates and sterilized the quarantine facility.

Comprehensive tests later identified the Zaire species identification as an error – Reston Ebola was a new species incapable of infecting humans. However, the enormous public health response was not unwarranted.

Unlike other Ebola species, researchers suspected Reston Ebola demonstrated airborne transmission at the quarantine facility. The longer the virus remained in human presence, the longer it was given opportunities to adapt. If Reston Ebola were to adapt to humans with airborne communicability it would pose a catastrophic public health risk.

Although no quarantine facility employees demonstrated Ebola-like symptoms during the 1989 outbreak, six workers produced Reston Ebola antibodies, meaning the virus elicited an immune response. Reston Ebola’s quick eradication was paramount to ensure that the virus—with its suspected airborne communicability—did not adapt to humans.

Restriction of the 2014 African Ebola epidemic to only a few countries has been attributed to the limited means of Ebola virus transmission. All Ebola species which affect humans are communicable only through direct contact with an infected person or their bodily fluids. Airborne transmission would increase viral spread and undermine containment efforts.

 

Image Credit

Pandora Report 8.31.14

Fall classes at George Mason have already started and this Labor Day weekend marks the official end of summer. This week, we have stories covering a wide range of topics—an Ebola update (of course), a fascinating article on vaccinia infections acquired through shaving, Haj precautions, and the ISIS “laptop of doom.”

Best wishes for a safe and enjoyable holiday!

Ebola Virus Outbreak Could Hit 20,000 Within Nine Months, Warns WHO

There were many stories this week covering the continuing Ebola outbreak in West Africa. Senegal saw its first (imported) case of the virus this week and has banned flights to and from the affected countries while shutting its land border with Guinea and Nigeria saw its first death outside of the capital city of Lagos. In the Democratic Republic of Congo, where Ebola first emerged in 1976, there have been reported cases of a hemorrhagic gastroenteritis similar to Ebola. I read conflicting accounts this week of the “patient zero” for the Ebola outbreak—a young boy or an older traditional healer. There were reports of some U.S. universities screening students from West Africa for Ebola. There was coverage of a Toronto medical isolation unit ready for patients and information about GlaxoSmithKline’s experimental ebola vaccine which would be tested on humans in the next few weeks.

All of this news came among World Health Organization estimates that this West African outbreak could affect 20,000 people over the next nine months and that half a billion dollars would be needed to stop the spread of the disease.

The Wall Street Journal—“The WHO program will likely cost around $490 million and require contributions from national governments, some U.N. and non-governmental agencies, as well as humanitarian organizations, it said.”

First Reported Spread of Vaccinia Virus Through Shaving After Contact Transmission

This week, reports in the August issue of Medical Surveillance Monthly Report from the Armed Forces Health Surveillance Center covered vaccinia virus infection—the virus used for smallpox vaccinations—within the U.S. Air Force. The infections in the report occurred in June 2014, and affected four individuals.

Infection Control Today—“Over the past decade, most cases of contact vaccinia (i.e., spread of the virus from a vaccinated person to an unvaccinated person) have been traced to U.S. service members, who comprise the largest segment of the population vaccinated against smallpox. Most involve women or children who live in the same household and/or share a bed with a vaccinee or with a vaccinee’s contact. Of adult female cases, most are described as spouses or intimate partners of vaccinees or secondary contacts. Of adult male cases, most involve some type of recreational activity with physical contact, such as wrestling, grappling, sparring, football, or basketball. Household interactions (e.g., sharing towels or clothing) and “unspecified contact” are also implicated.”

Government to Keep Haj Infection-Free 

This week, the Saudi Arabian Ministry of Health announced mandatory measures for Haj and Umrah pilgrims coming from countries with active outbreaks or high rates of infectious diseases. The Health Ministry sent information to embassies outlining health requirements for those seeking pilgrim visas.

Arab News—“‘Although we do not issue Haj visas for pilgrims coming from endemic countries, we will still be monitoring pilgrims coming from other African countries for Ebola symptoms,’ said [Sami] Badawood [Jeddah Health Affairs director.]

He said the ministry would also focus on diseases such as yellow fever, meningitis, seasonal influenza, polio and food poisoning.”

Is the ISIS Laptop of Doom an Operational Threat?

Discovery of a laptop, which has been linked to ISIS, raises new questions about the organization’s plans relating to use of WMD—specifically chemical or biological weapons. Over 35,000 files on the laptop are being examined and has offered new insight into ISIS and their WMD aspirations.

Foreign Policy—“Most troubling is a document that discusses how to weaponize bubonic plague. But turning that knowledge into a working weapon requires particular expertise, and it’s not clear that the Islamic State has it.”

 

Image Credit: Wikimedia Commons

Pandora Report 8.22.14

Did you see that the destruction of Syria’s most lethal chemicals is now complete? Well, it is! Its good news among so many biodefense stories covering Ebola. I have no interest in making the Pandora Report the “All Ebola, All the Time” newsletter. As such, we will look at one Ebola story as well as stories covering new discoveries in tuberculosis and influenza.

Have a fabulous weekend, and students, enjoy your last one before classes start on Monday!

Tuberculosis is Newer Than Thought, Study Says

A recent study published in Nature reports that tuberculosis originated less than 6,000 years ago and was carried to the new world by seals. Seals! This new research contradicts original timeline and species genesis and some scientists think this study provides more questions than answers.

The New York Times—“In the new paper, the team proposes that humans acquired tuberculosis in Africa around 5,000 years ago. The disease spread to people across the Old World along trade routes. Meanwhile, Africans also spread the disease to animals such as cows and goats. Seals that hauled out onto African beaches to raise their pups became infected. The bacteria then spread through seal populations until reaching South America. Ancient hunters there became infected when they handled contaminated meat.”

Enzyme Holds the Door for Influenza

As the fall season and semester approach, the flu season travels with it. I was delighted to read that Walgreens, in addition to CVS, will now offer seasonal flu shots in their stores. More interesting news about flu came out of Vanderbilt University, too. Researches have investigated enzyme phospholipase D (PLD) and it ability to help the influenza virus escape immune response. Blocking PLD could assist in preventing the flu.

Bioscience Technology Online—“Normally the virus slips into its host cell in the epithelial lining of the lungs through internalized membrane compartments called endosomes. By delaying this process, the researchers propose, PLD2 inhibitors may give the cell’s innate immune response more time to destroy it.”

Patient Checked for Ebola Virus in Sacramento

Internationally, the good news is that quarantines have been set up in Liberia, in attempt to contain the spread of Ebola. The bad news is that they have become fairly violent. Stateside, this week Dr. Kent Brantly and Nancy Writebol were released from Emory University Hospital after recovering from Ebola infections acquired in West Africa.

There was news of a possible case in Northern California. With few details provided as to the patient and transmission route, we learned that there is a patient being tested for Ebola in Sacramento. California Department of Health reported that the cases is low risk but that testing is being done out of “abundance of caution.”

San Francisco Chronicle—“‘In order to protect our patients, staff and physicians, even though infection with the virus is unconfirmed, we are taking the actions recommended by the CDC as a precaution, just as we do for other patients with a suspected infectious disease,” said Dr. Stephen Parodi, an infectious disease specialist at Kaiser Permanente North California. “This includes isolation of the patient in a specially equipped negative pressure room and the use of personal protective equipment by trained staff, coordinated with infectious disease specialists.’”

 

Image Credit

Image of the Day: CDC Ebola Infographic!

Ebola Infographic CDCOne thing you may not know about me is that I absolutely LOVE CDC infographics!

After this weekend’s events in Liberia, when people were seen carrying out bloody and fluid filled mattresses and other bedding, let’s take a look at how Ebola is actually transferred.

Please post this through your social media connections so we can work on spreading the correct information about the virus.

Pandora Report 8.17.14

Another 12 hours at Dulles Airport on Friday and, fortunately, no new travel alerts. This week we look at TB detecting rats, an experimental Chikungunya vaccine, and the latest from West Africa.

Giant Rats Trained to Sniff Out Tuberculosis in Africa

APOPO, the Belgian nonprofit organization known for using rats to sniff out land mines, has been training the African giant pouched rat to detect tuberculosis since 2008 in Tanzania and 2013 in Mozambique. The trained rats are used in medical centers in Dar es Salaam and Maputo to double check potential TB samples. The rats are unable to differentiate between standard and drug-resistant strains of the disease however, the cost of training and maintenance of the rats is significantly cheaper than the new GeneXpert rapid diagnostic tests.

National Geographic—“‘What the rats are trained to do is associate the smell of TB with a reward, so it’s what they call operative conditioning,’ [Emilio] Valverde [manager of the APOPO Mozambique TM Program] said.

It is the same principle applied to detecting land mines, only the rats are trained to recognize the scent of specific molecules that reflect the presence of the tuberculosis germ—not the explosive vapor associated with land mines.”

Experimental Chikungunya Vaccine Shows Promise

Chikungunya, of course, is one of the diseases included in the CDC’s travel alerts, and this week we learned of a promising vaccine for the disease that causes fever and intensely painful and severe arthritis. After the vaccine’s first human trials, the next step is to test in more people and more age groups, including populations where the virus is endemic. The trial leader said that it could be more than five years before a finished vaccine could be offered to the public.

CBS News—“‘This vaccine was safe and well-tolerated, and we believe that this vaccine makes a type of antibody that is effective against chikungunya,’ said trial leader Dr. Julie Ledgerwood, chief of the clinical trials program at the U.S. National Institute of Allergy and Infectious Diseases.”

WHO: Ebola Outbreak Vastly Underestimated

The news from West Africa seems to be getting worse and worse. Earlier in the week there was good news when a new quarantine center opened in Liberia. Then two days later, that same center was destroyed and looted. All of this comes, too, when the World Health Organization has said there is evidence that numbers of cases and deaths are far lower than the actual numbers and MSF has said that the outbreak will take at least six months to get under control.

Al Jazeera—“‘Staff at the outbreak sites see evidence that the numbers of reported cases and deaths vastly underestimate the magnitude of the outbreak,’ the organization said.

‘WHO is coordinating a massive scaling up of the international response, marshaling support from individual countries, disease control agencies, agencies within the United Nations system, and others.’”

Image Credit: James Pursey, APOPO

Ebola’s “Top-Secret” Serum: What Is It? Why Would It Be Kept Secret?

By Chris Healey

The deadliest and most pervasive Ebola outbreak in history is underway in Africa. As of August 8, the World Health Organization reported 1134 confirmed cases of Ebola in Guinea, Liberia, Nigeria, and Sierra Leone with 622 confirmed deaths.

Two Americans, Kent Brantly and Nancy Writebol, contracted Ebola while helping contain the epidemic in Africa. Both were flown to isolation units in Atlanta’s Emory University Hospital after receiving an experimental treatment called ZMapp. Brantly and Writebol’s condition is reportedly improving because of the drug.

ZMapp is the experimental brainchild of several pharmaceutical companies and their collaboration with the U.S. and Canadian governments. It is a combination of three antibodies determined to be the best components of two experimental Ebola treatments: MB-003 and ZMAb.

MB-003 is composed of a monoclonal antibody and an immune system stimulant. The monoclonal antibody binds to Ebola virus surface proteins to form a structure easily recognized as a threat by the host’s immune system. Mimicry allows the immune system stimulant to produce an inflammation-like response without causing tissue damage, serving to amplify immune response without damaging the host.

ZMAb, a combination of mouse-derived antibodies, inactivates Ebola virus surface proteins necessary for host cell entry. If Ebola virus cannot enter a host cell, it cannot cause illness. For higher efficacy, ZMAb antibodies target different parts of the surface proteins, making viral adaptation to the antibodies difficult.

ZMapp attracted much attention because it was used without being tested. Mapp Biopharmaceutical was preparing to enter Phase 1 clinical trials prior to the Ebola outbreak. Use of ZMapp in lieu of clinical trials is permitted by FDA regulations allowing drugs currently, or not at all, involved in clinical trials to be used in extenuating circumstances where no other pharmaceutical is appropriate.

ZMapp is not the first untested pharmaceutical to be used against Ebola in humans. In 2009, a researcher in Germany accidently exposed herself to Ebola virus when she pricked herself with an ebola-contaminated needle during a laboratory experiment. Within 48 hours, she was given an experimental Ebola vaccine never before used in humans. After 21 days, physicians prepared to discharge her from a Hamburg, Germany hospital because she had not developed any symptoms.

It is unclear if the vaccine prevented illness, or if the needle stick simply didn’t infect her with Ebola. Regardless, she produced Ebola virus antibodies after vaccine administration, indicating the vaccine produced an immune response.

When use of ZMapp was first reported, it was hailed in stories circulated by CNN as a “secret” and “top-secret” serum. However, current versions of the story now portray the serum as an “experimental drug.” It is unclear if the original reports of the serum’s secrecy were in error.

However, development of secret therapeutics is not farfetched. Classified treatments could conceivably serve national security interests.

State-sponsored bioweapon programs, for example, could use knowledge of existing therapeutics, such as those kept in the strategic national stockpile, to engineer biological agents resistant to available therapeutics. Such a tactic would cripple U.S. public health response to any weaponized agent. If ZMapp truly was classified, the U.S. may have been protecting the drug’s therapeutic mechanisms from those who would seek to overcome them.

Although withholding treatments would benefit the U.S., it raises ethical concerns. Some could argue treatment sequestration provides little benefit outside the U.S. A novel, effective treatment withheld in preparation for an attack –that may never occur– could be used in the present to treat the sick.

The merits of transparency must be weighed against interests of national security. For ZMapp, if it was classified, two American candidates for the drug were enough to bring it into the public domain.

 

Image Credit: International Business Times

Pandora Report 08.09.14

I spent about 12 hours at Dulles Airport yesterday. I didn’t fly anywhere, but I was ensuring that 120 international students were able to get from Washington DC to their host families all over the country. You may have noticed that in the security areas of Dulles Airport they have televisions that go over proper security screening procedures. On these same screens, they also show CDC travel alerts.

In June (when I was ensuring that 450 students were able to get back to their home countries), the alerts were for MERS and mosquito borne diseases like dengue and Chikungunya. Yesterday, Ebola was on alert for travelers to West Africa.

Last week we looked at the fever pitch of Ebola, today, lets look at the diseases designated by the CDCs travel alerts at Dulles.

 

Zika Virus: Another Threat from the Asian Tiger Mosquito

Travel alerts from the CDC often include Chickungunya and Dengue fever, but another disease from the same vector—the tiger mosquit0—is receiving alerts as well. Zika Fever, was isolated in humans in the 1970s, but has relatively few documented cases. In 2007, the virus demonstrated epidemic capacity with 5,000 cases in Micronesia. In 2013 there were 55,000 cases in Polynesia. Today the CDC has issued Watch Level 1 alerts for Zika in Easter Island, French Polynesia, and the Cook Islands and urges travelers to practice usual precautions.

Entomology Today—“Originally from Asia, the tiger mosquito was introduced to Africa in 1991 and detected in Gabon in 2007, where its arrival undoubtedly contributed to the emergence of dengue, chikungunya, and as shown by this new study, zika. The rapid geographic expansion of this invasive species in Africa, Europe, and America allows for a risk of propagation of zika fever around the world.”

 

Ramadan pilgrimage season in Saudi Arabia mostly free from MERS

Saudi Arabia reported only ten new cases of MERS from June 28- July 28 during the month of Ramadan. In April and May of 2014, hundreds of people were infected by MERS, which raised concerns about infection rates during Ramadan and during the Hajj, which will take place in October, when millions of pilgrims will travel to Mecca. Since 2012, Saudi Arabia has confirmed over 700 cases of infection resulting in nearly 300 deaths. The CDC designates the Hajj as an Alert Level 2, and urges U.S. residents to practice enhanced precautions.

Al Arabiya—“Saudi Arabia and the World Health Organization have said they are imposing no travel or other restrictions due to MERS during the Hajj, but have encouraged very young or old pilgrims, and those suffering from chronic disease, not to come this year.”

 

WHO: Ebola ‘an international emergency’

This week, the World Health Organization declared that the spread of Ebola in West Africa is an international health emergency. They urged coordinated response in order to keep the spread of the virus under control. Though no travel or trade bans have been enacted, the WHO recommends that Ebola cases or contacts should not travel internationally. This comes at a time when states of emergency have been declared in Liberia, Guinea, and Sierra Leone and the number of total cases has reached nearly 1,800 with over 950 deaths. The CDC designates outbreaks in these countries as a Warning Level 3, and urges U.S. residents to avoid non-essential travel.

BBC—“WHO director-general Dr. Margaret Chan appealed for help for the countries hit by the ‘most complex outbreak in the four decades of this disease.’

The decision by the WHO to declare Ebola a public health emergency is, by its own definition, an ‘extraordinary event’ which marks ‘a public health risk to other states through the international spread of disease’.”

 

Image Credit: The Denver Channel

Category A Bioterrorism Agent Lands in the U.S.

By Alena James

It has been one seriously scary and depressing summer with the multitude of cataclysmic events taking place all around the globe.  Much like the thousands of immigrant children whose futures are still being debated by the U.S. and Mexico, many of these crises have remained outside of U.S. soil. However, one potential crisis has been willingly brought to the U.S.

A few days ago a protocol was established to send medical evacuation planes to Liberia to bring back two missionary American health care workers suffering from the Ebola virus.  The decision to bring the patients back to the U.S. raised great alarm among many Americans that there is a chance of a major outbreak occurring with a disease that the U.S. is not prepared to fight

This past week, the Director of the CDC, Dr. Thomas Frieden, continually claimed that the necessary precautions were being taken to ensure the safety of the public from being exposed to the virus. According to Frieden, the chances of an outbreak taking place in the U.S. are minimal. Ebola is a virus that is not airborne and is not acquired through casual contact with an infected patient. For individuals to be infected they must have direct contact with bodily fluids septic (contaminated) with the virus.

During a CNN interview, Frieden explained that the decision to bring the Americans back to the U.S. was made by Samaritan’s Purse, the organization to which the two infected Americans, Dr. Kent Brantly and Nancy Writebol, belong. The role of the CDC will be to help assist in the transport and supportive care of the patients upon arrival at Emory University Hospital in Atlanta, Georgia.

The plane that transported Dr. Kent Brantly on Saturday was fitted with an Aeromedical Biological Containment System. In this system, a tent like structure was set up on board a modified Gulfstream III aircraft and used to isolate Brantly from the rest of the people onboard.

During an aeromedical evacuation, a patient undergoes medical assessment and evaluation before transport. This is to ensure the patient’s survival during the course of the trip. According to a study conducted by the U.S. Army Medical Research Institute of Infectious Diseases in Fort Detrick, Maryland, the physiologic effects of altitude, effect of confinement on patient-care delivery, and psychological effect of confinement within the containment system must be taken into consideration before transport.

Dr. Brantly arrived safely in the United States on Saturday at Dobbins Air Force Base in Marietta, Georgia. He was then transported to Emory University Hospital in Atlanta.

So, why exactly was the decision made to bring back to the Americans infected with a viral agent; which the CDC has classified as a Category A Bioterrorism Agent and to which there is no cure?

In his interview with CNN, Dr. Frieden, gave credit for the medical evacuation operation to Samaritan’s Purse. However, without the assistance of the State Department, the U.S. military, and the CDC it seems likely that the operation would not have come to fruition at all.

The reasoning for this evacuation, made by many advocates, seems to lie with the high level of confidence among those at the CDC and Emory University in their ability to control and contain the infected patients.  Despite the unprecedented nature of an Ebola patient returning to the U.S., infectious disease experts maintain the appropriate precautions are being made and the virus will remain contained.

The medical evacuation operations for Dr. Brantly and Nancy Writebol do not offer only an increased chance of recovery from Ebola and the chance to be reunited with their loved ones—if only through a glass partition. These operations also provide an opportunity for America’s best infectious disease experts and healthcare workers to gain firsthand experience with actual cases of a virus not available for study at clinical levels in the U.S. The medical evacuation operation is also beneficial to emergency response personnel who have been training on how to deal with these types of medical cases for years.

Over the summer, Americans watched intently as the creditability of the CDC took a hit when many of its laboratory staff failed to abide by proper laboratory safety techniques upon dealing with samples of Bacillus anthracis and H5N1.  The CDC and NIH’s credibility took another hit when the CDC discovered more than 200 vials of smallpox in a refrigerator in an NIH lab in Bethesda, Maryland.

Hopefully the fouls ups of the past have provided important lessons for all fields working with infectious diseases to take safety protocols very seriously…especially while working with patients suffering from a virus that has no cure.

 

Image Credit: Yahoo

Pandora Report 8.2.14

What a mess, right? While we here at the Pandora Report have been watching the Ebola outbreak in West Africa since March, it seems coverage in the news media has reached a fever pitch as the effects of the virus reach further and further.

This week we cover Ebola—a case in Nigeria, the evacuation of Peace Corps, the transfer of patients to the U.S. and treating the disease.

Nigeria Isolates Hospital in Lagos as Obama Briefed on Ebola Outbreak

Early in the week we learned of the first case of Ebola in Nigeria. It is important to note in this case, that the virus was imported from an American man, Patrick Sawyer, who travelled from Liberia. Fears rose over the importation to Africa’s most populous capital city—Lagos—and the hospital he was in was evacuated and is going through the process of decontamination.

Reuters UK—“Authorities were monitoring 59 people who were in contact with Sawyer, including airport contacts, the Lagos state health ministry said, but it said the airline had yet to provide a passenger list for the flights Sawyer used.

Derek Gatherer, a virologist at Britain’s University of Lancaster, said anyone on the plane near Sawyer could be in “pretty serious danger,” but that Nigeria was better placed to tackle the outbreak than its neighbors.”

Peace Corps Evacuates Ebola-Affected Region, With Two Volunteers in Isolation 

On Wednesday, the Peace Corps announced the evacuation of 340 volunteers from Guinea, Liberia, and Sierra Leone. Two volunteers from Liberia, however, were unable to leave. It is reported that the volunteers had contact with an individual who died from Ebola; they have to remain in an isolation ward for 21 days before leaving.

The Peace Corps—“The Peace Corps has enjoyed long partnerships with the government and people of Liberia, Sierra Leone and Guinea and is committed to continuing volunteers’ work there. A determination on when volunteers can return will be made at a later date.”

First Ebola Patient Arrives in U.S.

News came this week that two Americans infected with Ebola would be transferred to the U.S. for treatment at Emory University Hospital in Atlanta, GA.  Dr. Kent Brantly, who had been working at a treatment center in Liberia, was flown on a jet with a special containment area for patients with infectious diseases. He walked into Emory Hospital on Saturday unaided and is the first case of Ebola to arrive in the U.S.

Emory has an isolation unit built 12 years ago to treat patients exposed to highly infectious diseases.

Wall Street Journal—“Bruce Ribner, an infectious-diseases doctor and head of a special isolation unit at Emory University Hospital, said Friday there were good reasons to airlift the two to Emory. “We can deliver a substantially higher level of care, a substantially higher level of support, to optimize the likelihood that those patients will survive this episode,” he said.

Dr. Ribner added that he was “cautiously optimistic” the two have a good chance of recovery once they reach Emory, and that the transfer would be safe.”

Ebola Vaccine Possible, but Many Doubts Persist 

Vaccine development for Ebola has been being worked on for years, but with the increasing severity of this outbreak in West Africa, there has been discussion in the U.S. about fast-tracking vaccine trials for this virus. Even with this option—once approval is received from the FDA—many doubts persist and scientists who study the virus warn that the success is hardly guaranteed. Even if the vaccine proves to be effective in tests, questions remain as to who would receive it and how to figure out optimal dosages.

In short, even the development of vaccine candidates does not ensure success or virus eradication.

The New York Times—“The vaccine to be tested in humans relies on a benign virus that carries two proteins from the surface of the Ebola virus. The proteins help the virus penetrate human cells. If successful, the immune system will be trained to recognize the proteins and to mount a strong response should it encounter the virus.”

 

Image Credit: Atlanta Better Buildings Challenge

Pandora Report 7.26.14

Highlights this week include, Dr. Frieden goes to Washington, top Ebola doc comes down with the virus, a TB patient on the loose in California, and a plague based shut-down in China. Have a great weekend!

CDC Director to Tackle MERS, Measles, Global Health Threats

It was my absolute pleasure to be able to attend a talk given by Dr. Tom Frieden, Director of the Centers for Disease Control and Prevention, at the National Press Club on Tuesday.  Though Dr. Frieden briefly covered the stated topics, he spoke primarily about the dangers of growning antibiotic resistance and hospital acquired infections. He urged everyone, including the CDC, to work hard(er) to combat these issues that may usher us into a “post-antibiotic era.” The entire speech is available here. (You may even notice me in the lower left corner chowing down on a CDC cupcake!)

USA Today—“‘Anti-microbial resistance has the potential to harm or kill anyone in the country, undermine modern medicine, to devastate our economy and to make our health care system less stable,” Frieden said.

To combat the spread of resistant bacteria, Frieden said the CDC plans to isolate their existence in hospitals and shrink the numbers through tracking and stricter prevention methods.”

 

Sierra Leone’s Top Ebola Doctor Infected as the Worst Outbreak in History Continues

You may have seen this story pop up earlier this week in our facebook or twitter, but it certainly bears repeating. Dr. Sheik Umar Khan, who has been credited with treating more than 100 Ebola victims, has come down with the virus too. He is now one of hundreds who have been affected by the virus in West Africa, which has killed over 600.

The Washington Post-“In late June, Khan seemed keenly aware of the risk he faced. “I am afraid for my life, I must say, because I cherish my life,” he told Reuters. “Health workers are prone to the disease because we are the first port of call for somebody who is sickened by disease. Even with the full protective clothing you put on, you are at risk.’”

 

California Police Seek Man Who Refused Tuberculosis Treatment

Prosecutors in Northern California have obtained an arrest warrant for Eduardo Rosas Cruz, a 25 year old transient, who was diagnosed with TB and disappeared before he started treatment. Rosas Cruz needed to complete a nine-month course of treatment. Tuberculosis spreads through the air when an infected person coughs or sneezes. It is not known if Rosas Cruz is currently contagious. By law, health officials cannot force a patient to be treated but courts can be used to isolate an infectious individual from the public at large.

FOX News—“County health officials asked prosecutors to seek the warrant, in part, because Rosas Cruz comes from a part of Mexico known for its drug-resistant strain of tuberculosis. County health officials are searching for Rosas Cruz, and his name is in a statewide law enforcement system, San Joaquin County Deputy District Attorney Stephen Taylor said.”

 

In China, A Single Plague Death Means an Entire City Quarantined

Parts of Yumen City, in Gansu Province, were quarantined after a farmer died from bubonic plague. The man developed the disease after coming in contact with a dead marmot on a plain where his animals were grazing. According to experts, Chinese authorities categorize plague as a Class 1 disease, which enables them to label certain zones as “infection areas” and seal them off. 151 people were affected by the quarantine, which was lifted after none developed symptoms.

The Guardian—“The World Health Organization’s China office praised the Chinese government’s handling of the case. “The Chinese authorities notified WHO of the case of plague in Gansu province, as per their requirements under the International Health Regulations,” it said in a statement to the Guardian. “The national health authorities have advised us that they have determined this to be an isolated case, though they are continuing to monitor the patient’s close contacts.’”

 

Image Credit: RT